Merck Sues Teva Pharmaceuticals

  • January 20, 2012

Merck filed suit against Teva Pharmaceuticals over a patent related to montelukast sodium granule formation for Merck’s “Singulair” product.  1/11, District of New Jersey, 3:2012cv00210.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×